BeOne Medicines Ltd. - 10-Q Filing
BeOne Medicines Ltd. reports Q3 2026 financial results including revenue from Novartis and Amgen collaborations.
Tickers: $ONC
Read the full article at SEC EDGAR
Part of the story Amgen's Imdelltra Shows Significant Efficacy in Advanced Lung Cancer Treatment (2 articles)